PLIVA Announces Changes in Management and Supervisory Boards
PLIVA's Supervisory Board Appoints Three New Members to Management Board
Barr Pharmaceuticals, Inc. and its newly acquired subsidiary PLIVA d.d. announced changes to the Management and Supervisory Boards of PLIVA d.d. The changes resulted from the meeting of PLIVA's Supervisory Board that was held on October 30, 2006 in Zagreb, Croatia.
Following the successful closing of Barr's acquisition of PLIVA, Barr and PLIVA announced a new combined PLIVA management team with the appointment of three new members to PLIVA's Management Board. PLIVA's Management Board will continue to be led by Zeljko ovi as President and Chief Operating Officer and Ivan Mijatovi will remain as Member and Chief Financial Officer. Joining the Management Board will be Paul M. Bisaro, President and Chief Operating Officer of Barr Pharmaceuticals, Inc., Tim Sawyer, Vice President, Sales for Generic Products in Barr Laboratories, Inc., and Zdravka Knezevi, Executive Director of Global Research and Development in PLIVA, with a mandate through to June 30, 2010.
As a result of the combination and change in structure, Mike Urwin has elected to leave the Board but has agreed to stay on for an interim period to help ensure a smooth transition during the integration of both companies.
Other news from the department people
